Carrier-free self-assembled nanomedicine based on celastrol and galactose for targeting therapy of hepatocellular carcinoma via inducing ferroptosis

Celastrol induces ferroptosis in activated HSCs to ameliorate hepatic fibrosis via targeting peroxiredoxins and HO-1

Piao Luo, Dandan Liu, Qian Zhang et al. · Acta Pharmaceutica Sinica B · 2021 · 366 citations · Full text

Life Sciences, Molecular Biology, Pharmacology +17

Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine

P. J. Julyan · Journal of Controlled Release · 1999 · 180 citations

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +11

Celastrol in cancer therapy: Recent developments, challenges and prospects

Hannah Ying Lim, Pei Shi Ong, Lingzhi Wang et al. · Cancer Letters · 2021 · 118 citations

Medicine, Oncology, Pharmacology +9

Asialoglycoprotein receptor targeted delivery of doxorubicin nanoparticles for hepatocellular carcinoma

Sandhya Pranatharthiharan, Mitesh D. Patel, Vinod C. Malshe et al. · Drug Delivery · 2017 · 102 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

The asialoglycoprotein receptor in human hepatocellular carcinomas: its expression on proliferating cells

Davide Treré, L. Fiume, L. Badiali De Giorgi et al. · British Journal of Cancer · 1999 · 95 citations · Full text

Medicine, Molecular Biology, Oncology +17